Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-26

Clinical Trial Update: Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adding calcium channel blockers or diuretics to olmesartan medoxomil for hypertension has completed, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2009-08-26